Cancer Genetics Reports Third Quarter 2019 Financial Results and Provides Strategic Business Update
20 nov. 2019 08h00 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Nov. 20, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced strategic,...